SYNTERACTHCR SWEDEN AB

Closed at February 24th, 2024

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: MS
Martina Silvia Kröner1971
Operation time: 4 years; - Dec 5, 2020 to Feb 24, 2024
Type: Norwegian division of foreign business enterprise
VAT registered: No
Number of employees: 0

Last update: Jan 2, 2024

Management

Management / administration

Name	Role	Shares
MS Martina Silvia Kröner 1971	Managing Director/CEO	-

Board

Name	Role	Shares
S SYNTERACTHCR SWEDEN AB Closed	Information about the Company in the Home Country	-

Others

Name	Role	Shares
B BAKER TILLY GRIMSRUD & CO. ANS	Accountant	-

Last update: Apr 13, 2023

Ownership

No available data

Financials

in NOK

Summary

Year
Total operating income
Annual Total Result
Total assets
Total liabilities
Total equity

P&L

Year
Total operating income
Total operating costs
Operating result
Financial income/costs
Profit before tax
Total tax & extraordinary income/cost
Annual Total Result

Balance overview

Year
Total fixed assets
Total current assets
Total assets
Short term debt
Long term debt
Total liabilities
Contributed capital
Retained earnings
Total equity
Total equity and liabilities

Classification

21st company classification

BETA

Small company

SYNTERACTHCR SWEDEN AB925 934 623